Skeletal muscle loss during anti-EGFR combined chemotherapy regimens predicts poor prognosis in patients with RAS wild metastatic colorectal cancer için istatistikler

Toplam ziyaret

views
Skeletal muscle loss during anti-EGFR combined chemotherapy regimens predicts poor prognosis in patients with RAS wild metastatic colorectal cancer 0

Aylık toplam ziyaret

views
Ocak 2024 0
Şubat 2024 0
Mart 2024 0
Nisan 2024 0
Mayıs 2024 0
Haziran 2024 0
Temmuz 2024 0